Burcon Nutrascience Corporation
BU.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -101.32% | -51.46% | -83.86% | -2.44% | 14.64% |
| Total Depreciation and Amortization | -62.21% | 655.60% | 490.93% | 62.22% | 37.97% |
| Total Amortization of Deferred Charges | 0.40% | -1.03% | -1.04% | -6.14% | -2.84% |
| Total Other Non-Cash Items | 454.28% | 155.39% | 422.51% | 116.07% | 1.37% |
| Change in Net Operating Assets | -41.52% | -138.30% | -184.50% | 303.10% | -2,580.82% |
| Cash from Operations | -8.52% | -62.87% | -43.50% | 43.88% | 4.25% |
| Capital Expenditure | -834.34% | -1,802.51% | 16.28% | -224.47% | 76.20% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -415.79% | -212.26% | 46.05% | -7,629.23% | -63.46% |
| Cash from Investing | -1,641.67% | -4,097.85% | 28.88% | -17,829.31% | 80.77% |
| Total Debt Issued | 95.32% | -- | -- | -78.50% | -- |
| Total Debt Repaid | -12,278.57% | 28.04% | 86.73% | -160.12% | 39.13% |
| Issuance of Common Stock | -- | -- | -- | 115.64% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -159.76% | 100.00% | -260.73% | -246.04% | -- |
| Cash from Financing | 25.69% | -108.03% | -27.97% | 65.50% | 10,633.82% |
| Foreign Exchange rate Adjustments | -114.91% | 317.14% | -921.02% | -86.09% | 168.67% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.05% | -117.93% | -48.01% | 78.31% | 72.08% |